Loading company…
NeuroKaire develops precision medicine tests and services for central nervous system conditions.
NeuroKaire uses patient-derived cells and AI-enabled analysis to inform treatment strategies for central nervous system conditions. Its tests and services are designed for clinicians, researchers, and biopharmaceutical developers. Founded in Tel Aviv in 2017, the company raised USD 10.000 mn in December 2024, led by GreyBird Ventures, with JumpSpeed Ventures and Meron Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in